Intravenous and oral prenalterol in congestive heart failure: Effects on systemic and coronary hemodynamics and myocardial catecholamine balance

« Previous Next »The American Journal of Medicine
Volume 76, Issue 6 , Pages 999-1005, June 1984

Intravenous and oral prenalterol in congestive heart failure:

Dennis W. Wahr, M.D.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
Karl Swedberg, M.D.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
Michael Rabbino, M.D.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
- Current address: 1828 Camino Real, Suite 507, Burlingame, California 94010.
Margaret J. Hoyle, R.N., B.S.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
Deirdre Curran, A.B.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
William W. Parmley, M.D.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.
Kanu Chatterjee, M.B., F.R.C.P.
- Requests for reprints should be addressed to Dr. Kanu Chatterjee, University of California, Moffitt 1186, San Francisco, California 94143.
- From the Cardiovascular Division, Department of Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, California.